Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Infectious Diseases Therapeutics Market Research Reports

Titlepublishedprice

Dengue - Pipeline Insight, 2017

By Delve Insight
"...... on on the therapeutic development for Dengue, dealing with all the pipeline drugs and comparative analysis at various stages covering all clinical, pre-clinical as well as discovery products. The report further contains details on dormant products an......"
01-Nov-2017$1500

Influenza A Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Influenza A Infections which can turn out to be future prospective c......"
01-Nov-2017$2000

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Market Insights, Epidemiology and Market Forecast - 2025

By Delve Insight
"...... e) for the 7MM (United States, Germany, France, Italy, Spain and UK). The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Clostridium Difficile Infections (Clostridium Difficile Associated Disease) forec......"
01-Nov-2017$5750

 Varicella Zoster (HHV-3) Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... ucts including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Varicella Zoster (HHV-3) Infections......"
01-Nov-2017$2000

Vancomycin-Resistant Enterococcus Faecium Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... es information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Vancomyc......"
01-Nov-2017$2000

Sinusitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... s, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Sinusitis which can turn out to be future prospective competitors for the marketed products. I......"
01-Nov-2017$2000

Smallpox - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Smallpox which can turn out to be future prospective competitors for the marketed products. It w......"
01-Nov-2017$1500

Cryptococcosis - Pipeline Insight, 2017

By Delve Insight
"...... products. A comparative pipeline therapeutics assessment of Cryptococcosis by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products i......"
01-Nov-2017$1250

Postherpetic Neuralgia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Postherpetic Neuralgia which can turn out to be future prospective c......"
01-Nov-2017$2000

Global Common Cold Partnering 2010-2017

By Current Partnering
"...... • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agr......"
01-Nov-2017$1495

Avail upto 25% Discount on below Publisher Reports.